Inventor
CHRIS MURPHY
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides12%
Y02ATechnologies for adaptation to climate change12%
C07CAcyclic or carbocyclic compounds6%
C07DHeterocyclic compounds6%
G06FElectric digital data processing6%
G06NComputing arrangements based on specific computational models6%
G06QInformation and communication technology [ict] specially adapted for administrative, commercial, financial, managerial or supervisory purposes6%
PatentTitleYear
12,577,211Probenecid compounds for the treatment of inflammasome-mediated lung disease202612,421,281Cyclosporine compositions and methods of use202512,252,556Cyclosporine compositions and methods of use202511,612,608Methods of treating oral mucositis202311,562,312Productivity platform providing user specific functionality2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023Patents assigned to EMC IP HOLDING CO LLC (1)· patent assignee history
2023Patents assigned to GALERA LABS LLC (1)· patent assignee history
2023–2026Based in US· patent location history
2023Based in IE· patent location history
2025–2026Patents assigned to BACAINN BIOTHERAPEUTICS LTD (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BACAINN BIOTHERAPEUTICS LTD | 3 | 2025–2026 |
| EMC IP HOLDING CO LLC | 1 | 2023 |
| GALERA LABS LLC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2023–2026 |
| IE | 1 | 2023 |